Didier Blaise

1987–2025 年に発表

212
論文数
20,875
被引用数
85
h 指数
199
i10 指数

被引用数

Didier Blaise の年別被引用数1988 年: 被引用 2 件1989 年: 被引用 4 件1990 年: 被引用 2 件1991 年: 被引用 6 件1992 年: 被引用 2 件1993 年: 被引用 8 件1994 年: 被引用 9 件1995 年: 被引用 6 件1996 年: 被引用 6 件1997 年: 被引用 6 件1998 年: 被引用 13 件1999 年: 被引用 21 件2000 年: 被引用 36 件2001 年: 被引用 43 件2002 年: 被引用 56 件2003 年: 被引用 71 件2004 年: 被引用 44 件2005 年: 被引用 53 件2006 年: 被引用 32 件2007 年: 被引用 59 件2008 年: 被引用 73 件2009 年: 被引用 65 件2010 年: 被引用 83 件2011 年: 被引用 62 件2012 年: 被引用 69 件2013 年: 被引用 90 件2014 年: 被引用 86 件2015 年: 被引用 122 件2016 年: 被引用 92 件2017 年: 被引用 104 件2018 年: 被引用 86 件2019 年: 被引用 607 件2020 年: 被引用 715 件2021 年: 被引用 677 件2022 年: 被引用 530 件2023 年: 被引用 398 件2024 年: 被引用 831 件2025 年: 被引用 261 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,735 件、この内訳の 21.1%ドイツ: 引用元論文 671 件、この内訳の 8.2%フランス: 引用元論文 637 件、この内訳の 7.8%イタリア: 引用元論文 568 件、この内訳の 6.9%イギリス: 引用元論文 470 件、この内訳の 5.7%中国: 引用元論文 415 件、この内訳の 5%スペイン: 引用元論文 377 件、この内訳の 4.6%オランダ: 引用元論文 329 件、この内訳の 4%カナダ: 引用元論文 246 件、この内訳の 3%イスラエル: 引用元論文 238 件、この内訳の 2.9%スイス: 引用元論文 223 件、この内訳の 2.7%日本: 引用元論文 223 件、この内訳の 2.7%
0%21.1%その他 25.4%

分野

  • Medicine82.9%
  • Immunology and Microbiology11.3%
  • Biochemistry, Genetics and Molecular Biology4.1%
  • Engineering0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Computer Science0.2%
  • その他0.9%

トピック

  • Hematopoietic Stem Cell Transplantation17.3%
  • Acute Myeloid Leukemia Research9.3%
  • Immune Cell Function and Interaction6.5%
  • Acute Lymphoblastic Leukemia research6.3%
  • CAR-T cell therapy research5.7%
  • T-cell and B-cell Immunology4%
  • その他50.9%

共著者

全論文

検索で開く
  1. Defining the Intensity of Conditioning Regimens: Working Definitions

    著者: , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2009 被引用: 1,797

  2. A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 被引用: 121

  3. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matteo Giovanni Carrabba, Massimo Bernardi, Jacopo Peccatori, Cristina Barlassina, Elia Stupka, Dejan Lazarević, Giovanni Tonon, Alessandro Rambaldi, Davide Cittaro, Chiara Bonini, Katharina Fleischhauer, Fabio Ciceri, Luca Vago - Nature Medicine 2019 被引用: 402

  4. Targeting natural killer cells and natural killer T cells in cancer

    著者: , , , , - Nature reviews. Immunology 2012 被引用: 821

  5. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, Josè Antonio Pérez-Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic - Biology of Blood and Marrow Transplantation 2014 被引用: 435

  6. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rafael F. Duarte, Enric Carreras - Bone Marrow Transplantation 2016 被引用: 529

  7. Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fabio Ciceri, Jaime Sanz, Ali Bazarbachi, Arnon Nagler, Mohamad Mohty - Bone Marrow Transplantation 2020 被引用: 203

  8. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

    著者: , , , , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2020 被引用: 117

  9. Hematopoietic stem cell transplantation for patients with AML in first complete remission

    著者: , - Blood 2015 被引用: 337

  10. Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Virginie Lemiale, Bertrand Arnulf, Nicolas Boissel, Catherine Thiéblemont, Florence Rabian, Stéphanie Harel, Roberta Di Blasi, Julio Delgado, Valentín Ortiz‐Maldonado, Didier Blaise, Sabine Fürst, Faézeh Legrand, Christian Chabannon, Édouard Forcade, François‐Xavier Gros, Cécile Borel, Anne Huynh, Christian Récher, Jakob Rudzki, Kevin Rakszawski, Pierre Sesques, Emmanuel Bachy, Gilles Salles, Miguel‐Angel Perales, Philipp Wohlfarth, Thomas Staudingert, Ulrich Jäger, Guillaume Cartron, Nathalie Fégueux, Patrice Céballos, Laura Platon, Thomas Gastinne, Benoît Tessoulin, Amandine Le Bourgeois, Olga A. Gavrilina, Anna Sureda, Alberto Mussetti, Jorge Garcia Borrega, Peter Borchmann, Yi Lin, Reuben Benjamin, Sophie de Guibert, Quentin Quelven, Ibrahim Yakoub‐Agha, David Beauvais, Marie‐Thérèse Rubio - The Lancet Haematology 2021 被引用: 99

  11. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2015 被引用: 384

  12. Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

    著者: , , , , , , , , , , , , , , , - Blood 2019 被引用: 175

  13. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2023 被引用: 106

  14. Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2021 被引用: 104

  15. Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

    著者: , , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2022 被引用: 64

  16. Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT

    著者: , , , , , , , , , , , , , , , , , , , - Blood 2024 被引用: 47

  17. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

    著者: , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2018 被引用: 188

  18. The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2019 被引用: 162

  19. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2018 被引用: 251

  20. Anti-thymocyte globulin as graft- versus -host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , - Haematologica 2016 被引用: 137

  21. Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT

    著者: , , , , , , , , , , , , , , , , , , , , , - British Journal of Haematology 2018 被引用: 114

  22. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tapani Ruutu, Wael Saber, Bipin N. Savani, Robert J. Soiffer, Jan Styczyński, Elisabeth Wallhult, Ibrahim Yakoub‐Agha, Rafael F. Duarte, Enric Carreras - Bone Marrow Transplantation 2019 被引用: 112

  23. Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2020 被引用: 68

  24. High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 被引用: 60